Banque Pictet & Cie’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-104,962
Closed -$5.65M – 628
2022
Q3
$5.65M Sell
104,962
-9,182
-8% -$471K 0.06% 165
2022
Q2
$4.61M Sell
114,144
-4,170
-4% -$207K 0.05% 183
2022
Q1
$7.84M Buy
118,314
+14,124
+14% +$967K 0.06% 152
2021
Q4
$10.4M Buy
104,190
+86,082
+475% +$8.9M 0.08% 127
2021
Q3
$2.26M Buy
18,108
+4,492
+33% +$534K 0.02% 192
2021
Q2
$1.69M Buy
13,616
+3,599
+36% +$484K 0.02% 214
2021
Q1
$1.53M Buy
+10,017
New +$1.51M 0.02% 215

Other funds holding GH

Banque Pictet & Cie's GH Position: Q4 2022 in Review

Banque Pictet & Cie sold out of Guardant Health (GH) in Q4 2022, closing a stake of 104,962 shares — an estimated $5.65M sold.

Banque Pictet & Cie first reported a position in GH in Q1 2021 and held it in 7 quarters. The position peaked at $10.4M in Q4 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Banque Pictet & Cie reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 104,962 Guardant Health shares in Q4 2022, an estimated $5.65M.
  • Banque Pictet & Cie first reported a position in Guardant Health in Q1 2021 and held it in 7 quarters.
  • Banque Pictet & Cie's Guardant Health position peaked at $10.4M in Q4 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Banque Pictet & Cie's 13F filing for Q4 2022, filed 6 Feb 2023.